CV Advisors’s Ingevity NGVT Stock Holding History

CV Advisors’s Portfolio NGVT Stock Details NGVT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-3,725	Closed	-$278K	–	137
2026 Q2	$278K	Buy	+3,725	New	+$268K	0.05%	113

Other funds holding NGVT

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Royce & Associates New York $11B AUM 39.4% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $179B AUM 29.92% 1-Year Est. Return

Bessemer Group Woodbridge, New Jersey $72.8B AUM 32.97% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return

Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return

CV Advisors's NGVT Position: Q3 2026 in Review

CV Advisors sold out of Ingevity (NGVT) in Q3 2026, closing a stake of 3,725 shares — an estimated $278K sold.

CV Advisors first reported a position in NGVT in Q2 2026 and held it in 1 quarter. The position peaked at $278K in Q2 2026. 185 funds tracked by Wall St. Rank hold NGVT as of Q3 2026.

CV Advisors reported no remaining Ingevity position as of Q3 2026 after selling out during the quarter.
CV Advisors sold 3,725 Ingevity shares in Q3 2026, an estimated $278K.
CV Advisors first reported a position in Ingevity in Q2 2026 and held it in 1 quarter.
CV Advisors's Ingevity position peaked at $278K in Q2 2026.
185 funds tracked by Wall St. Rank held Ingevity as of Q3 2026.

Based on CV Advisors's 13F filing for Q3 2026, filed 13 Oct 2026.